Web Analytics Made Easy - StatCounter

Tofisopam Tenders

Get complete information related to latest Tofisopam Tenders . from India at Classic Tenders. Search the best available tenders from Indian government tenders, domestic Tofisopam Tenders , private tenders, online tenders, tender invitation notice, business tender notices, online tenders and bidding Tofisopam Tenders .

Filter
Loading....
Loading....
Loading....
Loading....
Loading....

Bid Submission Date Range
Tender Value

CTN :45284517 Due date: 01 Jun, 202601 Jun, 2026 NA
Tender For supply of drug eluting stent -sirolimous drug with biodegrable polymer on cobalt chromium platform with active coating. size ranging from length 08 mm to 48 mm and width 2.25 mm to 5.0 mm. the quoted stent to be at least dcgi approved and three years efficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented/published in peer reviewed scientific journals. the documents pertaining to the efficacy and safety of the stent should be enclosed for the brand that is offered in the tender bid. replacement warranty against any manufacturing defect noted onthe o.t. table. the original company brochure mentioning the range of sizes (diameter & length) should besubmitted along with tender. [ai(2026-27), item code-no: s-62066, sl no.2010] ]

CTN :45302891 Due date: 09 Jun, 202609 Jun, 2026 28.78 Lacs
Tender For supply of metoprolol xr 50 mg tab , midazolam 5mg slash ml nasal spray , midodrine 5 mg tab , mometasone plus azelastine nasal spray , moxifloxacin 0 point 5 percentagew slash v plus keterolac , naphazoline 0 point 1 percentagew slash v plus chlorpheniramine , naproxen 500 mg plus domperidone 10 mg tab , naproxen gel tube of 20 gm , nitrofurantoin 50 mg tab , olmesartan 10 mg tab , orlistat 120 mg tab , oxaliplatin 100 mg inj , oxaliplatin 50 mg inj , oxcarbazepine 600 mg tab , paracetamol 325 mg plus tramadol 37 point 5 mg tab , phenobarbitone 60 mg tab , pilocarpine 5 mg tab , pinaverium bromide 50 mg tab , placenta extract 0 point 1 gm gel , povidone iodine 5 percentage tube of 15 gm oint , pramipexole 0 point 375 mg tab , rabeprazole 20 mg plus domperidone 30 mg tab , relugolix 120 mg tab , risedronate 35 mg tab , rituximab 100mg inj , roflumilast 500 mg tab , rosuvastatin 10 mg plus fenofibrate 145 mg tab , saccharomyces boulardii 250 mg sachet , salmeterol 25 mcg plus fluticazone propionate 250 mcg 120 doses mdi , sertaconazole 2 percentage 30 gm tube oint , simethicone 80 mg tab , somatrogon 24 mg growth hormone inj , telmisartan 40 mg plus amlodipine 5 mg plus hydrochlorothiazide 12 point 5 mg tab , tetrabenazine 25 mg tab , thalidomide 50 mg tab , tizanidine 2 mg plus ibuprofen 400 mg tab , tobramycin 0 point 3 percentagew slash v plus loteprednol 0 point 5 , tocilizumab 162mg slash 0 point 9ml inj , tofisopam 50 mg tab , tolvaptan 30 mg tab , tretinoin gel 0 point 04 percentage , trifluoprazine 5mg plus trihexyphenidyl 2mg tab , trimetazidine hdrochloride er 80 mg tab , urea plus lactic acid cream , urobag , vincristine 1 mg inj , vitamin c 300 mg plus vitamin b3 25 mg plus folic acid 10 mg plus , vitamin d3 oral solution 60000 iu , vitamin e 400 mg cap , vonoprazan 20 mg tab , vortioxetine 10 mg tab , white soft paraffin 13 point 2 percentage light liquid paraffin liquid , amoxycillin 875 mg plus clavulanic acid 125 mg , insulin premixed biphasic 40 iu per ml 30 percentage human neutral plus 7 , sodium valporate 200 mg tab , mesalamine 5 amino salicylic acid sr 1 point 2 gm delayed release tab //bid details 2 / 48

Central Government/Public Sector

CTN :45249380 Due date: 10 Jun, 202610 Jun, 2026 NA
Tender For e-tender for procurement of essential drug items under table-a, for one year from the date of aoc. - amitriptyline hcl tab.i.p. 10mg., aripiprazole tab 5 mg, cefpodoxime oral suspension 50mg/5ml, cefpodoxime proxetil 200 mg tab i.p, ciprofloxacin hcl tab. i.p. 500mg (scored ), clindamycin inj. 600mg./ 4 ml amp/vial., doxycyclin capsules 100mg, glimipride 2 mg tab, ibuprofen i.p. 400 mg tab., isoniazid tab.i.p. 300mg, levetiracetam ip tab 500 mg, levetiracetam syrup 100 mg/ ml in 100 ml bottle, lignocaine hcl gel i.p 2% w/w, meropenem inj 500mg/vial, metformin tab 500 mg (sr/pr/er), o.r.s i.p. as powder for reconstitution,cont.:sod. chloride 2.6gm.,dextrose (anhydrous13.5gms ,pot.cl 1.5 & sod.citrate 2.9gms (total 20.5per packet)., omeprazole caps.i.p. 20mg., oseltamivir syrup ip (oseltamivir phosphate) 12 mg/ml, 75 ml phial, pantoprazole 40 mg. tab. (enteric coated), paracetamol 1000 mg tab., paracetamol i.p. 125 mg. tab., paracetamol i.p. 500 mg. tab., paracetamol i.p. 650 mg. tab. (scored), pramipexole tab 0.25mg, prednisolone tab 10 mg, propranolol hcl tablet i.p. 10mg, propranolol hcl tablet i.p. 40mg, salbutamol syrup i.p. 2mg./5ml., telmisartan tab 80 mg, tramadol hcl 50 mg tab., important note: 1. all prospective bidders are requested to quote the rate in boq as per accounting unit & item specification as mentioned in the table-a. wrong quoting of the rate in boq will be dealt with as per penal provisions of the t&c of the tender.2. tendered quantity is just a tentative quantity and should not be treated as final. it may increase or decrease, as per need of the state. keeping this in mind, the supplier is not allowed to seek termination of the rate contract after finishing supply of tendered quantity.3. quality of the product supplied, may be ascertained by testing / physical examination by the experts at any stage of the tender period.4. the prospective bidders of the said tender are requested to make a declaration in affidavit under annexure vi(b) in case of sole manufacturer/importer (i.e. proprietary in nature).5. if the item(s) under sole manufacturer / importer is (are) proprietary in nature, quarterly intimation is solicited from the approved bidders positively regarding the status of their item(s) proprietary in nature, otherwise their item(s) will be blocked in the smis.6. in case of tie bid, decision will be taken by the tia as per g.o. no. 2320-f(y), dated 07.06.2022 issued from finance department audit branch (group t).

Central Government And Public Sector

CTN :45296307 Due date: 06 Jun, 202606 Jun, 2026 19.22 Crore
Tender For supply of waiting bench individual bed types , auditorium chair , auditorium conference hall 150 desk and chair for 2 students , auditorium conference hall 100 desk and chair for 2 students , desk , waiting bench for 3 persons , sofa set 3 seater , platform bed , table and wall mounted table required lab item for medical purpose , for storage cubical post forming custom made frame and shutters only , for storage cubical post forming custom made , main desk , return desk , joining table rhs , mobile pedestal oxford cherry , back unit oxford cherry , main table with side unit , mid back chair , conference table 6 seater ta , 3 seater sofa fab brown , 1 seater sofa fab brown , attendent bed cum chair , single static push and pull type storage ss1 , single static push and pull type storage sl1 , single static push and pull type storage tm1 solid back panel , channels rails p1 by p2 chnl 2400 mm , channels rails p1 by p2 chnl 1600 mm , flod table , acousticical grid false ceiling , administrative block sls printed fabric ceiling , administrative block veneer ceiling paneling , veneer wall paneling , fluted veneer wall paneling , nilaya ray skin wall paper pattern , nilaya straight up wall paper pattern , mdf beading with c trim , fluted veneer ceiling paneling , subtex clouds nubby kontour grafix bild , liso spots nano plus bild , for auditorium astral plus malla clip- in melange bild , for guest house veneer ceiling paneling , for guest house fluted veneer ceiling paneling , for guest house veneer wall paneling , for guest house fluted veneer wall paneling , for guest house nilaya sabyasachi wall paper pattern , for gust house nilaya bolta apex cord wall paper pattern , for guest housemdf beading with c trim , for guest house marmofresco texture paint , reception table , dining table , wooden dining chair , curtains , king cot , single cot , bedside cabinet , drug trolley cart 12 drawer , emergency crash cart , examination couch with step stool , icu motorised bed with mattress 5 function height head trendlendurg and leg , instrument trolley , instrument medicine cabinet , iv stand 4 pole height adjustable , manual bed with mattress 4 function height head leg and trendlendurg , overbed table adjustable , step stool 2 step , strecher without height adjustment , stretcher with height adjustment hydraulic oxygen cylinder iv pole , wheel chair foldable , wheel chair with cushion , air mattress , gynec examination couch , mayos trolley , revolving stool with cushion top , autopsy table with motorised movement , wheelchair motorised

Central Government/Public Sector

CTN :45254443 Due date: 03 Jun, 202603 Jun, 2026 NA
Tender For srphc82281240-coronary drug eluting stents with (1) stent on cobalt chromium alloy or platinum chromium alloy. (2) stent with coating of polymer carrier for active drug ( sirolimus, everolimus or zotarolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm and length of the stent should be 12mm to 48mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval shouldbe enclosed in the tender bid. (9) the long term efficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals. (10) the documents related to the efficacy and safety of the stent should be only for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent toa major government institute.[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]

CTN :45252717 Due date: 29 May, 202629 May, 2026 NA
Tender For supply of dglp drugs gem 03 niv disp 2026 27 g g - ltr packs , high potency calcium carbonate 1000mg magnesium hydroxide 240mgzinz 11mg and vit d3 500 iutab , waterless surgical hand antiseptic lotion chlorhexidine gluconate 1percentsolution and ethyl alcohol 61percentw w 1200ml , inj thiopentone 0dot5gm without water , quitiapine 25 mg tab , clomipramine 50mgtab , amisulpride 50 mg tab , amitriptyline 10 mg tab , aripiprazole 5 mg tab , mirtazepine 7dot5 mg tab , hydrogel colloid ointment 15 gm , inj ceftriaxone 1 g plus disodium adetate 37mg plus sulbactum 1 gm , inj ceftazidime 2 mg plus avabactum 0dot5 mg , niacinamidebutylene glycol enantia chlorantha bark extract oleanolic acid cream 50 gm , tab thalidomide 50 mg , tab thalidomide 100 mg , tab acyclovir 400 mg , corn cap , potassium permanganate crystals pack of 10gm , tolterodine 2mg la cap , mirabegrone 50 mg tab , nitrofurantoin macrosystaline sr 100mg tab , albumin powder 400gm , cholestyramine 4gm 5gm , inj ertapenem 1gm , inj anidulafungin 100mg , inj aztreonam 2gm , inj carbetocin 100 mcg ml , inj vit d 6 lac iu , inj doxycycline 100 mg , inj voriconazole 500 mg , inj clindamycin 600 mg , inj ceftriaxone 1000 mg plus disodium edetate 37 mg plus sulbactum 500 mg powder for infusion , tab empagliflozine 10mg plus linagliptin 5 mg , live freeze dried capsule lactic acid bacteria and bifidobacteria 112dot5 billlion cfu , cap amoxycillin plus tab clarithromycin plus tab esomeprazole 750mgplus500mgplus40mg , tab tenofovir alafenamide 25 mg , tab naltreoxone 25 mg , inj aqueous progesterone 50 mg , human menopausal gonadotropin 300iu inj , cream oestrdiol 1mg gm 15 gm with applicator , tab rifampicin 150mg plus isoniazid 75mg plus pyrazinamide 400mg plus ethambutol 275mg , tab rifampici 150mg plus isoniazid 75mg plus ethambutol 275mg , ketamine hydrochloride inj ip 50 mg ml 10 ml , 20percent intralipid 100 ml , tab citicoline 500 mg plus piracetam 800 mg , tab methylphenidate 5 mg , tab lemborexant 5 mg , tab thiamine 100 mg , tab varenicline 0dot5 mg , inj vitamin d3 600000 iu , tab tolvaptan 7dot5 mg , tab elobixibat 5 mg , tab acotiamide 100 mg , tab gavilson aluminium hydroxide 95 mg plus magnesium carbonate 358 mg , inj insulin lispro 200 iu ml in 3ml pfs , twinrab rabies monoclonal containing docaravimab 1500 iu 2dot5 ml with doseas erig 40iu kg , inj dantrolene sodium 20mg 10ml , inj phenylephrine 50mcg ml vial of 10 ml , inj zuclopenthixol 50 mg , inj zuclopenthixol 200 mg , tab tofisopam 50 mg , tab pregabalin 75 mg plusntp 10 mg , tab pimavanserin 34 mg , inj paliperidone 75 mg , tab methylphenidate sr 20 mg , tab atomoxetine 25 mg , tab nafithromycin 800mg , tab 12 sq hdm sublingual lyophilisate , inhalar budesinide glycopyrronium and formaterol fumarate dihydrate pressurized inhalation suspension 160 7dot2 5dot0mcg , tab bisoprolol fumarte 5 mg plusprindopril arginine 10 mg , tab trimetazidine extended release 80 mg , inj semaglutide 2mg 1dot5 ml , inj romiplostim 250 mg , tab vericignat2dot5mg , tab vericignat 5mg , tab vericignat 10mg , tab lemborexant 10mg , inj doxycycline 100mg vial , inj polymixin b 5lac unit vial , inj penicillin g , tab modafanil100mg , bacillus clausii spores oral suspension , lactobacillus paracasei gmnl 33 and cichorium intybus root oro dental tablet , ceftriaxone 2000mg sulbactum1000 mg and disodium edetate 74 mg , cefepime 2gm plus enmetazobactum 500 mg dry powder for injection , levonadifloxacin iv injection //bid details 2 / 91 800mg 100ml , multienzyme cleaning solution for instruments , tab tizanidine 2 mg , tab rimegepant 75 mg , sachet vigabatrin 500 mg , nerivio device , tab melatonin 3mg , tab melatonin 6mg , inj protamine sulphate 50 mg 5ml , omega 3 fatty acid , gla 120 gamma linolenic acid capsules , tab l carnitine 500 mg , magnesium coenzyme q10 , tab mirabegron er 50 mg , tab isoprirosine 500 mg , tab riluzole 50 mg , rotigotine transdermal patch 2mg 24h

Central Government/Public Sector

CTN :45227572 Due date: 15 Jun, 202615 Jun, 2026 NA
Tender For srphc82281210-coronary drug eluting stents (1) single wire technology on cobalt based alloy platform (2) stent with coating of biolinx polymer carrier for active drug zotarolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.25 mm to 4 mm and length of the stent from 12mm to 38 mm. (4) the strut thickness should be 81 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) five years long term efficacy and safety of the stent in terms of target vesselrevascularisation (tvr) and in-situ thrombosis (ist) should be documented / published inpeer reviewed scientific journals.(10) the documents pertaining to the efficacy and safety of the stent should be enclosed for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent to a major government institute.[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]

Central Government/Public Sector

CTN :45227573 Due date: 15 Jun, 202615 Jun, 2026 NA
Tender For srphc82281275-des-abbreviated dapt long -coronary drug eluting stents with (1) platinum chromium alloy (2) coating of bioabsorbable polymer carrier for activedrug everolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm. the length of the stent should be from 12mm to 48 mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) the long term efficacy and safety of the stent, the rates of in-stent restenosis (isr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals. (10) safety of abbreviated (three month) dual antiplatelet therapy for high bleeding risk patients should be documented in peer reviewed journals. (11) the manufacturer/supplier should submit proof of supply of the stent to a major government institute. bis standards for the drug eluting stent are not available. (reference:bis catalogue ).[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]

Central Government/Public Sector

CTN :45227584 Due date: 16 Jun, 202616 Jun, 2026 NA
Tender For srphc82281225-coronary drug eluting stents with (1) cobalt chromium alloy (2) coating of bioabsorbable polymer carrier with abluminal and gradient coating foractive drug shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm . the length of the stent should be from 12mm to 38 mm. (4) the strut thickness should be 91 micron or less. (5) stent delivery system should bemonorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) the long term efficacy and safety of the stent, the rates of in-stent restenosis (isr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals. (10) safety of abbreviated (one month) dual antiplatelet therapy for high bleedingrisk patients should be documented in peer reviewed journals. (11) the manufacturer/supplier should submit proof of supply of the stent to a major government institute. bis standards for the drug eluting stent are not available. (reference:bis catalogue ).[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]

Central Government/Public Sector

CTN :45227585 Due date: 16 Jun, 202616 Jun, 2026 NA
Tender For srphc82281280-des-pt/cr : coronary drug eluting stents (1) on platinum chromium platform (2) stent with coating of polymer carrier for active drug everolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter shouldbe from 2.5mm to 4mm and length of the stent from 12mm to 38 mm. (4) the strutthickness should be 91 micron or less. (5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design should be open cell type. (8) stent should be approved bydcgi . the copy of dcgi approval should be enclosed in the tender bid. (9) the long termefficacy and safety of the stent in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals.(10) the documents pertaining to the efficacy and safety of the stent should be enclosed for the brand that is offered in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent to a major government institute.[quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 lacs ] ]
 Loading, Please wait...

Connect us via What's Up